. 2017 Mar 15;2(5):478–487. doi: 10.1001/jamacardio.2017.0063

Table 3. Risk of Mortality After Ischemic and Bleeding Events During the 21-Month Postrandomization Period.

Variable	Adjusted HR (95% CI) for Mortality^a
Ischemic events
MI not related to ST	9.1 (6.1-13.6)
Definite or probable ST	14.6 (8.2-25.9)
Ischemic stroke	13.1 (7.2-23.8)
Any MI, definite or probable ST, or ischemic stroke	12.6 (9.0-17.6)
Bleeding events
GUSTO moderate bleed	8.0 (4.7-13.7)
GUSTO severe bleed	36.3 (23.3-56.6)
GUSTO moderate or severe bleed	18.1 (12.6-26.0)
BARC 2, 3, or 5 bleed	9.3 (6.6-13.1)
BARC 2 or 3 bleed	5.7 (3.8-8.4)
BARC 3 or 5 bleed	16.2 (11.2-23.5)
BARC 2 bleed	3.4 (1.9-6.1)
BARC 3 bleed	8.6 (5.5-13.4)

Abbreviations: BARC, Bleeding Academic Research Consortium; GUSTO, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries; HR, hazard ratio; MI, myocardial infarction; ST, stent thrombosis.

^{^a}

Adjusted models were stratified by propensity score quintile. Propensity scores were derived from all variables included in Table 1 and Table 2.